![Charles Hugh-Jones](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Charles Hugh-Jones
Vorstandsvorsitzender bei Volastra Therapeutics, Inc.
Aktive Positionen von Charles Hugh-Jones
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Volastra Therapeutics, Inc.
![]() Volastra Therapeutics, Inc. BiotechnologyHealth Technology Volastra Therapeutics, Inc. develops novel therapies for patients with metastatic cancers. The company was founded by Lewis Cantley, Samuel Bakhoum and Olivier Elemento and is headquartered in Boston, MA. | Vorstandsvorsitzender | - | - |
Karriereverlauf von Charles Hugh-Jones
Ehemalige bekannte Positionen von Charles Hugh-Jones
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ALLERGAN PLC | Technik-/Wissenschafts-/F&E-Leiter | 14.08.2018 | 08.05.2020 |
Statistik
International
Irland | 2 |
Vereinigte Staaten | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 1 |
Chief Executive Officer | 1 |
Sektoral
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Allergan Ltd. (Ireland)
![]() Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
Volastra Therapeutics, Inc.
![]() Volastra Therapeutics, Inc. BiotechnologyHealth Technology Volastra Therapeutics, Inc. develops novel therapies for patients with metastatic cancers. The company was founded by Lewis Cantley, Samuel Bakhoum and Olivier Elemento and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- Charles Hugh-Jones
- Erfahrung